Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04357353 · ClinicalTrials.gov registry record · Phase 3
The Role of Platelet Rich Plasma for Erectile Dysfunction
A Phase 3 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT04357353 is a Phase 3 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 13 participants.
The verdict
NCT04357353, a Phase 3 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
Interventions
- BIOLOGICAL Platelet rich plasma
- OTHER Placebo Sham Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-11-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04357353
The ClinicalTrials.gov registry entry for NCT04357353 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelet rich plasma is the first listed.
NCT04357353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04357353 about?
NCT04357353 is a clinical study titled "The Role of Platelet Rich Plasma for Erectile Dysfunction". Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
What is the current status of trial NCT04357353?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2021-04-01. Estimated completion is 2022-11-02.
What interventions are being tested in trial NCT04357353?
The interventions under investigation include: Platelet rich plasma (BIOLOGICAL), Placebo Sham Injection (OTHER).
Who is sponsoring clinical trial NCT04357353?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.